|
|
|
|
|
|
|
FIG. 2
Why do projects fail? |
|
|
|
|
|
|
|
|
parallel track strategy moving more than one candidate into development from a discovery program to hedge the risk. Does this make sense? |
|
|
|
|
|
|
|
|
Several factors are worth considering. First, why do projects fail in early development? Some data on this has been published by the Centre for Medicines Research (Ref. [5] and Fig. 2). Anti-infective projects comprised some 77 of the 198 compounds included in this survey and distorted the |
|
|
|
|
|
